Strategy Index ETF (OPTZ) Touches a New 52-Week High

For investors seeking momentum, Optimize Strategy Index ETF OPTZ is probably on the radar now. The fund just hit a 52-week high and jumped 63.2% from its 52-week low price of $29.04 per share.But are there more gains in store for this ETF? Let’s take a quick look at the fund and its near-term outlook to get a better sense of where it might head.   OPTZ in FocusThis fund provides exposure to innovative American companies that exhibit a favorable profile with regard to various fundamental metrics, including the ratio of current earnings per share (EPS) over the trailing 10-year average EPS, the current Price to Earnings (P/E) ratio, and the 2-year forward EPS growth estimate for large capitalization companies and the Price to Sales (P/S) ratio for small capitalization companies. The product charges 25 basis points (bps) in annual fees (See: Style Box-All Cap Blend ETFs here).What Led to the Rise?The fund’s recent 52-week high peak is likely driven by its rules-based allocation to high-growth tech and semiconductor giants. With top holdings like Advanced Micro Devices and Micron Technology, the fund has capitalized on the massive capital influx into artificial intelligence infrastructure. This tech boom, combined with strong multi-cap earnings growth, must have made OPTZ an attractive vehicle for investors looking to ride the current wave of hardware and data center expansion.More Gains Ahead?OPTZ may continue its strong performance in the near term, with a positive weighted alpha of 64.74 (as per Barchart.com), which suggests a further rally.    Boost Your Portfolio with Our Top ETF InsightsZacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week.Don’t miss out on this valuable resource. It’s free!Get it now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks